Previous 10 | Next 10 |
Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2023 J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 11:15 a.m. PST. A live webcast of the conference will be available at investor.alcon.com/news-and-events/events-and-presentations . About Alcon ...
Mizuho has initiated Alcon ( NYSE: ALC ) with a buy saying that eyecare company is a recession hedge as the company is the No. 2 player in the global contact lenses market and No. 1 in cataract implants. The firm has a $85 price target (~24% upside based on Wednesday's close). Ana...
Alcon Inc. ("Alcon") (SIX/NYSE: ALC) announced that it has commenced and priced a private offering of US$700 million aggregate principal amount of its 5.375% senior notes due 2032 and US$600 million aggregate principal amount of its 5.750% senior notes due 2052 (together, the “Notes”...
Leveraging Alcon’s robust commercial capabilities and resources to drive further growth and access to Rocklatan and Rhopressa Acquisition adds pharmaceutical research and development capabilities and further expertise for future product pipeline Expands Al...
Alcon Inc. (ALC) Q3 2022 Earnings Conference Call November 16, 2022, 8:00 AM ET Company Participants Dan Cravens - Vice President and Global Head, Investor Relations David Endicott - Chief Executive Officer Tim Stonesifer - Chief Financial Officer Conferenc...
The following slide deck was published by Alcon Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Alcon Inc. 2022 Q3 - Results - Earnings Call Presentation
Trading on Wall Street got off to a quiet start on Wednesday, with investors generally taking a pause after extremely high volatility levels over the past several weeks. Most major market indexes eased lower, giving back small portions of their recent gains. However, even with earnings ...
Alcon ( NYSE: ALC ) has lowered its 2022 net sales outlook to $8.5B to $8.7B, down from $8.6B to $8.8B in August. The consensus revenue estimate is $8.74B. The eye care company also tightened its diluted EPS range for the year to $2.20-$2.25 from $2.20-$2.30 in August....
Alcon press release ( NYSE: ALC ): Q3 Non-GAAP EPS of $0.50 beats by $0.01 . Revenue of $2.12B (+1.9% Y/Y) misses by $10M . Updated 2022 outlook reflects strong sales growth and operational leverage, negatively impacted by strong US dollar. Core operating m...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Last week the markets saw their best single-session gain in more than two years as investors celebrated the favorable Consumer Price Index ( CPI ) reading. And then today’s Producer Price Index (PPI) had Wall Stree...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 17:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Combined vitreoretinal-cataract system (VCS) and standalone cataract system (CS) are cleared for use in the U.S. New, proprietary technologies designed to deliver transformative surgical innovation Alcon to immediately begin collecting real-world user experience in the U.S. prior ...
2024-06-09 17:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...